Chairman of scientific council of RIGVIR
Prof. Kalviņš is president of Latvian Academy of Sciences; member of scientific council of Institute of Organic Synthesis (OSI); inventor of anti-ischemic drug Meldonium and anti-cancer immunostimulator Leakadine, Meldonium GX, new Meldonium-containing pharmaceutical compositions, as well as, drug candidates under clinical trials Belinostat and Neramexane; author of more than 500 publications and 500 patent applications.
Awarded with a certificate and Golden Medal of World Intellectual Property Organization (WIPO).
Head of R&D pharmacologist / drug development scientist
Honorary Doctor of Medicine of Latvian Academy of Sciences, Honorary Member / Recipient of the O. Schmiedeberg Medal, Latvian Pharmacological Society.
Has more than 25 years experience of different drug development and registration projects in Latvia, Sweden, Denmark and Switzerland.
Author of more than 50 scientific publications indexed in PubMed.
President and CEO Sinorda
Was leading drug discovery at several global pharmaceutical companies such as AstraZeneca, Pharmacia (late Pfizer) and Biovitrum. Director of translational medicine research in Guizhou Medical University Hospital in China, Centre of Cancer Immunotherapy and Molecular Diagnosis and Cancer immunotherapy.